Well-regarded real estate investment company,
Alexandria Real Estate Equities (ARE), has recently seen an array of developments. The firm was downgraded to a
Sell Rating by StockNews.com while Jefferies initiated coverage with a
Hold Recommendation. The company experienced significant stock activity, with firms like
Cibc World Market Corp and First Financial Bankshares Inc purchasing shares while others, like
Natixis Advisors and Swiss National Bank, reducing their holdings. ARE has announced a
public offering of $550,000,000 of Senior Notes due 2035, a $500 Million common stock repurchase program and a cash dividend of $1.32 per common share for 4Q24. The 2025 Q1 operational and financial results conference call is scheduled for
April 29, 2025. Alexandria was also named one of the world's most trustworthy companies by Newsweek. Key emphasize on its ongoing strategic interventions includes entering a long-term 258,581 RSF lease agreement with Vaxcyte, Inc. at the Alexandria Center for Life Science and the closure of a strategic value-harvesting disposition for 1165 Eastlake Avenue East in Seattle.
Alexandria Real Estate Equities ARE News Analytics from Mon, 22 Apr 2024 07:00:00 GMT to Sat, 22 Mar 2025 09:46:15 GMT -
Rating 4
- Innovation 7
- Information 3
- Rumor 6
